REGENECYTE
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for REGENECYTE, covering 2025-03-24 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition